Chelsea Handler says she took Ozempic without knowing it

Comedian Chelsea Handler said on the Call Her Daddy podcast that she took Ozempic without knowing it, adding that her anti-aging doctor "just hands it out to anybody." She said she only realized what she had been prescribed after a friend described the same nausea she was experiencing. The story quickly became a talking point about how loosely some concierge and anti-aging practices prescribe the drug, sometimes without patients fully understanding what they are taking.

Ozempic's active ingredient is semaglutide, the same compound sold as Wegovy for obesity and as Rybelsus in pill form ^[1]. Ozempic itself is approved only to treat type 2 diabetes, and weight loss is a documented side effect, which is why doctors sometimes prescribe it off-label for weight management ^[1]. Novo Nordisk, the company that makes Ozempic, has told reporters it does not support off-label use of its medications ^[1]. Similar drugs made by Eli Lilly, tirzepatide sold as Mounjaro for diabetes and Zepbound for obesity, work on a related mechanism and have also become part of the broader celebrity conversation about weight-loss medications ^[1].

Handler's account is part of a much larger pattern of celebrities speaking publicly about GLP-1 drugs, though their stories vary widely in how they describe the process. Some, like tennis star Serena Williams, say they turned to a GLP-1 after trying rigorous diet and exercise changes without success ^[1]. Others, including actor Eric Stonestreet, say a doctor recommended the drug specifically to manage a diagnosed condition, in his case type 2 diabetes, and that he takes Mounjaro for that reason ^[1]. Oprah Winfrey has said she uses a weight-loss drug as a tool to avoid regaining weight, describing it as something she once viewed as an "easy way out" before changing her view ^[1]. These accounts show a range of paths onto the medications, from careful, condition-specific prescribing to Handler's description of a doctor handing the drug out broadly.

Why it matters for patients

Handler's anecdote raises a practical concern for patients: not knowing exactly what medication you have been prescribed makes it harder to recognize side effects, understand risks, or discuss the drug with other doctors and pharmacists. Nausea, which Handler said tipped her off, is a commonly reported side effect across GLP-1 medications, but patients who don't know they're on a GLP-1 drug may not connect symptoms to the medication or communicate that history accurately during other medical care.

The episode also underscores a distinction that patients may not always get clearly explained: Ozempic is FDA-approved for type 2 diabetes, not weight loss, even though weight loss is a known effect and a common reason doctors prescribe it off-label ^[1]. Wegovy, by contrast, carries the obesity approval ^[1]. Patients navigating concierge or anti-aging clinics may benefit from asking directly which drug and which approved use applies to their prescription, since the source material shows even public figures have sometimes been unclear on these details themselves.

What is not established in the available reporting is how common Handler's experience is, how her doctor described the prescription to her at the time, or what specific dose she was given. Those specifics are not addressed in the sources reviewed here and remain unknown based on what has been reported.